Search research articles
Contact Us
Filters
Showing results (1-10 of 134) with videos related to
Page
of 14
Sort By:
Current Opinion in Immunology
|
March 27, 2018
Engineering T cells for adoptive therapy: outsmarting the tumor
Andre Kunert, Reno Debets
Immunotherapy
|
July 9, 2013
Genetically modified T lymphocytes: more than just direct effectors
Cor H J Lamers, Reno Debets
Journal of Immunology (Baltimore, Md. : 1950)
|
November 25, 2022
Detection of Low-Frequency Epitope-Specific T Cells in Blood of Healthy Individuals according to an Optimized In Vitro Amplification System
Shweta Mahajan, Dian Kortleve, Reno Debets, et al.
Seminars in Immunology
|
March 22, 2016
TCR-engineered T cells to treat tumors: Seeing but not touching?
Reno Debets, Emmanuel Donnadieu, Salem Chouaib, et al.
Molecular Cancer
|
October 17, 2025
Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy
Rui M L Coelho, Reno Debets, Dora Hammerl
Trends in Immunology
|
April 13, 2022
Cancer germline antigens and tumor-agnostic CD8<sup>+</sup> T cell evasion
Dian Kortleve, Rui M L Coelho, Dora Hammerl, et al.
Expert Opinion on Biological Therapy
|
September 18, 2018
Consumption of β-glucans to spice up T cell treatment of tumors: a review
Priscilla de Graaff, Coen Govers, Harry J Wichers, et al.
Human Immunology
|
January 1, 2003
Genetic engineering of T cell specificity for immunotherapy of cancer
Ralph A Willemsen, Reno Debets, Patrick Chames, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 27, 2022
Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy
Dian Kortleve, Mandy van Brakel, Rebecca Wijers, et al.
Trends in Molecular Medicine
|
February 4, 2010
T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing
Coen Govers, Zsolt Sebestyén, Miriam Coccoris, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 134) with videos related to
Sort By:
Page
of 14
Current Opinion in Immunology
|
March 27, 2018
Engineering T cells for adoptive therapy: outsmarting the tumor
Andre Kunert, Reno Debets
Immunotherapy
|
July 9, 2013
Genetically modified T lymphocytes: more than just direct effectors
Cor H J Lamers, Reno Debets
Journal of Immunology (Baltimore, Md. : 1950)
|
November 25, 2022
Detection of Low-Frequency Epitope-Specific T Cells in Blood of Healthy Individuals according to an Optimized In Vitro Amplification System
Shweta Mahajan, Dian Kortleve, Reno Debets, et al.
Seminars in Immunology
|
March 22, 2016
TCR-engineered T cells to treat tumors: Seeing but not touching?
Reno Debets, Emmanuel Donnadieu, Salem Chouaib, et al.
Molecular Cancer
|
October 17, 2025
Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy
Rui M L Coelho, Reno Debets, Dora Hammerl
Trends in Immunology
|
April 13, 2022
Cancer germline antigens and tumor-agnostic CD8<sup>+</sup> T cell evasion
Dian Kortleve, Rui M L Coelho, Dora Hammerl, et al.
Expert Opinion on Biological Therapy
|
September 18, 2018
Consumption of β-glucans to spice up T cell treatment of tumors: a review
Priscilla de Graaff, Coen Govers, Harry J Wichers, et al.
Human Immunology
|
January 1, 2003
Genetic engineering of T cell specificity for immunotherapy of cancer
Ralph A Willemsen, Reno Debets, Patrick Chames, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
May 27, 2022
Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy
Dian Kortleve, Mandy van Brakel, Rebecca Wijers, et al.
Trends in Molecular Medicine
|
February 4, 2010
T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing
Coen Govers, Zsolt Sebestyén, Miriam Coccoris, et al.
Page
of 14